PURPOSE . To evaluate the capabilities of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in patients with early stages glaucoma. METHODS The study included 38 primary open-angle glaucoma who underwent MP-TSCPC SUPRA 810 (“Quantel Medical”, France) as surgical treatment. follow-up period averaged 17±11 months (from 6 to 30 months). Kaplan-Meier scale was used assess cumulative success ...

Purpose:To evaluate the safety and efficacy of transscleral cyclophotocoagulation (TSCPC) in patients requiring additional intraocular pressure reduction following Baerveldt glaucoma implant (BGI) surgery. Methods: Twenty eyes that underwent TSCPC with the red (810nm) diode laser between April 2005 and January 2010 were retrospectively reviewed. All patients had previously undergone placement o...